IRIS
SESSAREGO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.761
AS - Asia 775
NA - Nord America 335
SA - Sud America 64
AF - Africa 11
OC - Oceania 2
Totale 9.948
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.623
SG - Singapore 343
US - Stati Uniti d'America 312
CN - Cina 215
VN - Vietnam 125
FR - Francia 66
BR - Brasile 36
HK - Hong Kong 29
JP - Giappone 14
AR - Argentina 13
DE - Germania 12
MX - Messico 12
CH - Svizzera 11
FI - Finlandia 11
IQ - Iraq 10
BD - Bangladesh 9
GB - Regno Unito 9
ID - Indonesia 7
CA - Canada 6
EC - Ecuador 5
IN - India 5
NL - Olanda 4
RU - Federazione Russa 4
VE - Venezuela 4
ZA - Sudafrica 4
CO - Colombia 3
ES - Italia 3
IE - Irlanda 3
KZ - Kazakistan 3
TR - Turchia 3
AU - Australia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
UZ - Uzbekistan 2
AL - Albania 1
BE - Belgio 1
BS - Bahamas 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 9.948
Salva come PNG Salva come JPEG
Città #
Genova 5.534
Genoa 1.805
Rapallo 748
Vado Ligure 505
Singapore 148
San Jose 133
Lauterbourg 62
Ashburn 49
Ho Chi Minh City 38
Hong Kong 28
Hanoi 26
New York 23
Beijing 22
Bordighera 13
Tokyo 12
Frankfurt am Main 11
Helsinki 11
Zurich 11
Santa Clara 10
Los Angeles 9
Mexico City 8
Orem 8
São Paulo 7
Tianjin 6
Baghdad 5
Buffalo 5
Haiphong 5
Hải Dương 5
Amsterdam 4
Biên Hòa 3
Cardiff 3
Da Nang 3
Dublin 3
Montreal 3
Paris 3
Piscataway 3
Resistencia 3
Antakya 2
Atlanta 2
Belgrade 2
Bắc Ninh 2
Can Tho 2
Dallas 2
Denver 2
London 2
Nairobi 2
Poplar 2
Quito 2
Rome 2
Sydney 2
Toronto 2
Tosno 2
Vĩnh Long 2
Warsaw 2
Addis Ababa 1
Aguascalientes 1
Ahmedabad 1
Al Hillah 1
Allegheny County 1
Almaty 1
Amman 1
Ankara 1
Araruama 1
Araucária 1
Arroyo Dulce 1
Asunción 1
Atyrau 1
Augusta 1
Avellaneda 1
Bari 1
Bassano Romano 1
Berazategui 1
Bogotá 1
Bombinhas 1
Boston 1
Brasília 1
Brooklyn 1
Brussels 1
Buenos Aires 1
Bình Dương 1
Bến Tre 1
Campina Grande do Sul 1
Campinas 1
Campo Bom 1
Cape Town 1
Carapicuíba 1
Caruaru 1
Casablanca 1
Cascina 1
Cassano Magnago 1
Castel Mella 1
Charlotte 1
Chicago 1
Copenhagen 1
Corrientes 1
Council Bluffs 1
Criciúma 1
Cuenca 1
Curtea de Argeş 1
Del Viso 1
Totale 9.355
Salva come PNG Salva come JPEG
Nome #
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 228
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. 223
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 211
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia 211
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 209
Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course 206
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis 198
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 197
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 194
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 192
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study 191
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 188
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 186
HMGA2 overexpression in plycythemia vera with t(12;21) (q14;q22) 177
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 174
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 171
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 169
Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease. 166
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 165
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 163
Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy. 159
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker 157
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemia. 156
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 153
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 149
Variant Philadelphia translocations in CML: correlation with fragile sites. 149
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 148
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor cell rescue for metastatic breast cancer 141
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 140
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 140
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11 139
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis 138
Assocition of -318C/T and +49A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of italian patients with systemic sclerosis 137
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 137
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 137
Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia 136
Unusual Ph translocations in CML: four new cases 136
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication 136
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. 135
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 135
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 134
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 132
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 131
Masked Philadelphia chromosome caused by translocation (9;11;22) 130
Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities. 125
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time 119
Preparation of colony stimulating activity from human leukemic urine: hydrophobic chromatography on propylamine-agarose. 119
Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization 118
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 114
Thrombocytosis in subjects with chronic myelocytic leukemia in blastic metamorphosis. Clinical remarks and therapeutic considerations (5 case reports). 113
Demonstration of phosphoglucomutase 1 in a subclone of the K-562 cell line 112
Composition of human granulocytic colonies as a function of the purification stage of CSF. 112
Related Articles, Links Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. 111
Coincidence between fragile site expression and interstitial deletion ofchromosome 11 in a case of myelofibrosis 107
Erythroid differentiation of erythroleukemic line K562 (S) with arabinofuranosylcytosine: isolation of a non inducible clone. 107
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia 106
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia. 105
Urinary colony-stimulating factor in acute leukemia follow-up and correlation with various phases of the disease. 105
Mixed chimerism after allogeneic marrow transplantation. 101
Marked karyotype abnormalities in two cases of acute myelogenous leukemia. 101
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 100
Expression of erythroid acetylcholinesterase in the K-562 leukemia cell line 98
Fibroblastoid colony-forming cells in myeloproliferative disorders. 94
Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques. 94
Isolation and characterization of a K562 cell lineresistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction. 93
Marrow colony stimulating activity in chronic myelogenous leukemia. 93
Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic response. 93
Regulation of acetylcholinesterase expression in the K-562 cell line 88
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score). 87
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases. 81
Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease. 80
Totale 9.980
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.996
article - articoli 27.996
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 47 35 47
2021/2022844 21 41 79 90 39 69 36 201 40 91 24 113
2022/2023890 93 71 15 98 159 169 0 62 148 5 66 4
2023/2024428 23 55 8 50 25 114 24 37 19 5 21 47
2024/20251.208 25 114 43 61 170 119 94 197 54 49 132 150
2025/20261.888 311 84 55 146 274 224 418 89 122 165 0 0
Totale 9.980